U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: May 19-25, 2019
  1. FDA Meetings, Conferences and Workshops

Public Calendar: May 19-25, 2019

Public Calendar: May 19-25, 2019

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Norman E. Sharpless, M.D. (Acting), Commissioner of Food and Drugs

Event Date: 05/23/2019
Location: North Bethesda, MD
Subject: Foundation for the National Institutes of Health Board Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Several National Institutes of Health Board Members

Official Name: Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

No Significant Event

Official Name: Lowell J. Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Acting Deputy Commissioner for Global Regulatory Operations and Policy

Event Date: 05/21/2019
Location: Peking China
Subject: 2019 Drug Information Association (DIA) China Annual Meeting: Remarks on Globalization
FDA Participant/Group: LEIGH VERBOIS
Non FDA Participant/Group: Several attendees from the Drug Information Association China 2019 meeting

Event Date: 05/23/2019
Location: Beijing, China
Subject: Quality Culture
FDA Participant/Group: SANDI VERBOIS;
Non FDA Participant/Group: Several faculty and students from the Peking University Health Science Center (PKUHSC) and the International Pharmaceutical Engineering Management (IPEM) programs

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 05/21/2019
Location: Silver Spring, MD
Subject: United States – Canada Joint Committee on Food Safety
FDA Participant/Group: CAMILLE BREWER; LARRY MORRIS; ANNA FERUS; JEFFREY READ; MICHAEL ROGERS; STEVEN SOLOMON; BRUCE ROSS; KEITH JASUKAITIS; DOUGLAS STEARN; CAROLINE DEWAAL; DONALD PRATER;
Non FDA Participant/Group: Barbara Doan, Christophe Delombaerde, Fred Gorrell, Jodi White, Luc Rivard, Nancy Rheault, Parthi Muthukumarasamy, Tammy Switucha, Tania Polcyn (Canadian Food Inspection Agency);

Event Date: 05/21/2019
Location: Silver Spring, MD
Subject: The Institute of Food Technologists Meeting: Food Safety
FDA Participant/Group: DOUGLAS STEARN; NINA ZIMDAHL; LAUREN BERKOWITZ; REBECCA BUCKNER; CAITLIN BOON; KARI BARRETT;
Non FDA Participant/Group: Andy Kennedy, Bryan Hitchcock, Maria Velissariou, Thomas Burke (Institute of Food Technologists); Denise Bode, Kevin Swanson (Michael Best & Friedrich LLP);

Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name: Keagan Lenihan, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 05/21/2019
Location: Cleveland, OH
Subject: Case Western Reserve University: Cell-Based Therapies and Tissue Engineering Short Course: FDA and Cell-Based Therapies: Past, Present, and Future
FDA Participant/Group: N/A
Non FDA Participant/Group: Several graduate students, post-graduate students, and health science professionals

Event Date: 05/21/2019
Location: Boston, MA
Subject: Harvard Stem Cell Institute 14th Annual Retreat: Facilitating the Development of Advanced Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Several researchers from the stem cell and regenerative medicine group

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 05/21/2019
Location: Silver Spring, MD
Subject: Medical Devices (AFX and AFX2 Endovascular AAA Systems) Meeting
FDA Participant/Group: BRIAN PULLIN; CHIH HSIN LIU; BRAM ZUCKERMAN; DOROTHY ABEL; ARON YUSTEIN; JOSE MORALES; ROBERT LEE; ADAM SALTMAN; VALERIE MERKLE; MEGAN GATSKI; NICOLE IBRAHIM; REBECCA WARD;
Non FDA Participant/Group: Elisa Hebb, Genevieve Dunbar, Jeff Fecho, John Onopchenko, Leslie Norwalk, Matt Thompson (Endologix, Inc.); Kenneth Ouriel (Syntactx);

Event Date: 05/22/2019
Location: Grand Rapids, MI
Subject: Michigan Medical Device Summit: FDA Town Hall: Update on CDRH Priorities and the Latest in Regulatory Guidances and Decisions on Medical Technology Products
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

Event Date: 05/20/2019
Location: Dallas, TX
Subject: American Thoracic Society 2019 Conference: Nicotine and the FDA Perspective: Regulation, Science, Patient Education and Clinical Practice: Nicotine: FDA Policy and Regulation
FDA Participant/Group: PRISCILLA LYON;
Non FDA Participant/Group: N/A

Event Date: 05/21/2019
Location: Rochester, MN
Subject: Mayo Clinic: Annual Nicotine Dependence Center Conference: Comprehensive Overview of FDA's Regulatory Strategy for E-Cigarettes and Tobacco Products
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

Event Date: 05/22/2019
Location: Phoneix, AZ
Subject: Seventh Annual Conference on Governance of Emerging Technologies and Science: Governance of New Technologies from the Perspective of Regulators
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members from academia, leaders of industry; and several policy makers